Lixil Viva Corp (3564)

Tokyo

Currency in JPY

2,593.0

0.0(0.00%)

Closed·19/10

Day's Range

2,593.0

2,600.0

52 wk Range

2,593.0

2,600.0

3564 Income Statement

Featured here, the Income Statement (earnings report) for Lixil Viva Corp, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

1995

28/02

1996

29/02

1997

28/02

1997

31/08

1998

31/03

2001

31/03

2015

31/03

2016

31/03

2017

31/03

2018

31/03

Total Revenues

aa.aa

91,109

174,619

179,814

182,948

184,809

Total Revenues Growth

aa.aa

+67.88%

+91.66%

+2.98%

+1.74%

+1.02%

Cost Of Revenues

aa.aa

65,345

115,031

117,809

119,724

120,696

Gross Profit

aa.aa

25,764

59,588

62,005

63,224

64,113

Gross Profit Growth

aa.aa

+105.95%

+131.28%

+4.06%

+1.97%

+1.41%

Gross Profit Margin %

aa.aa

28.28%

34.12%

34.48%

34.56%

34.69%

Other Operating Expenses, Total

aa.aa

24,959

49,910

51,692

52,592

53,396

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+80.73%	+99.97%	+3.57%	+1.74%	+1.53%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	24,959	49,910	51,692	52,592	53,396
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

805

9,678

10,313

10,632

10,717

Operating Income Growth

aa.aa

+161.92%

+1,102.24%

+6.56%

+3.09%

+0.8%

EBIT Margin %

aa.aa

0.88%

5.54%

5.74%

5.81%

5.8%

Net Interest Expenses

aa.aa

154

-631

-776

-811

-615

Net Interest Expenses Growth

aa.aa

+43.93%

-509.74%

-22.98%

-4.51%

+24.17%

Interest Expense, Total

aa.aa

-97

-755

-890

-910

-722

Interest And Investment Income

aa.aa

251

124

114

107

Other Non Operating Expenses, Total

aa.aa

138

296

119

-70

EBT, Excl. Unusual Items

aa.aa

1,006

9,185

9,833

9,940

10,032

Gain (Loss) On Sale Of Assets

aa.aa

-662

-810

4,525

Other Unusual Items, Total

aa.aa

-976

-446

-479

-330

EBT, Incl. Unusual Items

aa.aa

-674

8,459

13,912

9,471

9,719

EBT, Incl. Unusual Items Growth

aa.aa

+64.32%

+1,355.04%

+64.46%

-31.92%

+2.62%

EBT, Incl. Unusual Items Margin

aa.aa

-0.74%

4.84%

7.74%

5.18%

5.26%

Income Tax Expense

aa.aa

-1,599

3,091

4,627

2,926

3,011

Net Income to Company

aa.aa

925

5,368

9,285

6,545

6,708

Minority Interest

aa.aa

Net Income

aa.aa

925

5,368

9,285

6,545

6,708

Net Income Growth

aa.aa

+148.23%

+480.32%

+72.97%

-29.51%

+2.49%

Net Income Margin %

aa.aa

1.02%

3.07%

5.16%

3.58%

3.63%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

925

5,368

9,285

6,545

6,708

Basic EPS - Continuing Operations

aa.aa

0.14

134.2

232.13

163.63

150.44

Basic EPS - Continuing Operations Growth

aa.aa

+148.27%

+98,287.1%

+72.97%

-29.51%

-8.06%

Diluted EPS - Continuing Operations

aa.aa

0.14

134.2

232.13

163.63

150.44

Diluted EPS - Continuing Operations Growth

aa.aa

+98,287.1%

+72.97%

-29.51%

-8.06%

Basic Weighted Average Shares Outstanding

aa.aa

6,781.52

44.59

Diluted Weighted Average Shares Outstanding

aa.aa

6,781.52

44.59

Dividend Per Share

aa.aa

80.65

Dividend Per Share Growth

aa.aa

-59.08%

+24.24%

EBITDA

aa.aa

2,237

15,561

15,898

EBITDA Growth

aa.aa

+2.17%

EBITDA Margin %

aa.aa

2.46%

8.51%

8.6%

EBIT

aa.aa

805

9,678

10,313

10,632

10,717

* In Millions of JPY (except for per share items)

NSE 30

5,152.99

+13.06

+0.25%

NSE All Share

141,439.75

+435.61

+0.31%

US 30

45,401.70

-230.0

-0.50%

US 500

6,460.50

-6.4

-0.10%

FTSE 100

9,321.40

+12.20

+0.13%

DAX

24,249.84

-120.90

-0.50%

South Africa Top 40

95,329.31

+262.45

+0.28%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	10.900	-0.91%	87.12M
Guaranty Trust Holding	96.05	+2.18%	25.00M
Access Holdings	27.45	+1.67%	15.69M
UBA	47.95	0.00%	14.23M
Zenith Bank	70.00	0.00%	10.18M
Aradel Holdings	510.00	-1.73%	2.66M
Julius Berger	146.10	+9.93%	2.15M

Name	Last	Chg. %	Vol.
Julius Berger	146.10	+9.93%	2.15M
Cutix	3.900	+9.86%	2.13M
Regal Insurance	1.47	+9.70%	15.85M
Veritas Kapital	2.17	+9.60%	58.37M
McNichols	3.50	+9.37%	677.72K
Nem	28.950	+8.83%	529.28K
Universal Insurance PLC	1.32	+8.20%	33.56M

Name	Last	Chg. %	Vol.
University Pre	5.540	-12.06%	681.46K
Cadbury Nig	57.85	-9.61%	660.41K
Abbey Mortgage Bank	6.55	-8.39%	254.88K
Daarcomm	1.12	-7.44%	3.04M
Austin Laz	2.71	-6.55%	2.59M
Mecure Industries	19.50	-6.02%	421.01K
Tantalizers	2.50	-5.66%	4.86M

Trending Stocks

Name	Last	Chg. %	Vol.
Mutual Benefits Assurance	4.45	+1.14%	18.05M
MTN Nigeria	435.00	0.00%	707.31K
Aiico	4.47	+6.94%	26.20M
Dangote Cement	520.00	0.00%	111.45K
Betaglas	449.35	0.00%	142.48K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaaaaaaaa Aaaa	5,379.30	+46.90%	7,902.19
Aaaaaaa A A	520.00	+35.88%	706.58
Aa Aa A Aaaaaaaaaa	151.80	+31.85%	200.15
Aaaaaaaaaaaaaaaaaaa	1,890.00	+30.65%	2,469.28
Aaaa Aaaaaa	70.20	+18.13%	82.93
Aaaa Aaaa A	640.00	+17.25%	750.40

Name	Last	Upside	Fair Value
Aaa Aaaaaaaaa Aaaa	5,379.30	+46.90%	7,902.19
Aaaaaaa A A	520.00	+35.88%	706.58
Aa Aa A Aaaaaaaaaa	151.80	+31.85%	200.15
Aaaaaaaaaaaaaaaaaaa	1,890.00	+30.65%	2,469.28
Aaaa Aaaaaa	70.20	+18.13%	82.93
Aaaa Aaaa A	640.00	+17.25%	750.40

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Lixil Viva Corp (3564)

3564 Income Statement

Trending Stocks